Searched for
NOVARTIS STOCK
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- Citi sees India IPOs hitting fresh records despite challengesIndian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equity markets extended losses for a fourth straight session as broad-based selling in IT, banking, auto, and consumer stocks dragge...
- Global Markets | European shares subdued as US-Iran talks stall; corporate earnings on tapEuropean shares were muted on Tuesday as investors braced for a week packed with central bank meetings and corporate earnings, while weighi...
- Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 croreSwiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This div...
- Market volatility derails Novartis' plan to sell stake in its India armNovartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strate...
- Novartis puts its India-listed entity for up for saleThe strategic review will include an assessment of the 70.68% shareholding of Novartis AG in Novartis India. Novartis said there is no assu...
- Novartis launches new share buyback of up to $15 blnThe Swiss pharma company confirmed it expected sales to grow by 4% or more through 2026. Its capital allocation strategy aims to combine in...
- Novartis India denies delisting plans; stock plunges over 13%The stock had ended 15.72 per cent in previous trade following media reports that “Novartis AG was planning to delist Indian units.
- Novartis buys GSK's cancer drugs for $14.5 billion in a 3-way dealThe collaboration between the two will create a new world-leading consumer healthcare business with $10 billion in annual sales.
- Novartis India shares up 4% after Swiss-promoter says to cut stakeShares of Novartis India today closed higher by 3.75 per cent, adding Rs 68 crore to its market capitalisation, after its Swiss-promoter sa...
- Novartis AG to reduce promoters stake in Novartis IndiaAs per the shareholding pattern of the company, as on September 30, 2012 Novartis AG had 76.42 stake in Novartis India.
- Novartis India Q1 net up 19.15 pc at Rs 37.57 crDrug firm Novartis India on Monday said its net profit for the quarter ended June 30, 2011 rose by 19.15 per cent to Rs 37.57 crore.
- Novartis India Q3 net up 74.94 pc to Rs 40.50 crDrug firm Novartis India today said its net profit rose by 74.94 per cent to Rs 40.50 crore for the third quarter ended December 31, 2010, ...
- Novartis to buy Aventis stake in rabies vaccine JV for $22 millionAventis Pharma, the Indian arm of Sanofi Aventis, is exiting its joint venture Chiron Behring Vaccines by selling its 49% to the other part...
- Novartis hikes offer price for arm to Rs 450Novartis AG, the Swiss pharma giant, has increased the open offer price for its subsidiary Novartis India to Rs 450 from Rs 351 per share.
- Novartis soars 20 pc as Swiss parent sweetens offer priceSwiss drug firm Novartis AG sweetened its open offer price to Rs 450 a share for acquiring an additional 39 per cent stake in its Indian su...
- Novartis open offer for Indian arm to begin on May 20Swiss Drug maker Novartis AG's open offer for acquiring an additional 39 pr cent stake in its Indian subsidiary will begin on May 20.
- Novartis' open offer hangs in balanceThe fate of the open offer of Swiss pharma giant Novartis to scale up its stake in its Indian subsidiary Novartis India looks uncertain wit...
- Novartis open offer for Indian arm to begin on May 14Swiss drug maker Novartis AG's open offer for acquiring an additional 39 per cent stake in its Indian subsidiary will begin on May 14.
Load More
